Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Bovie Medical has signed an agreement with Boston Scientific to acquire technology, patents, and assets related to the use of conductive sintered steel as an electrode for radio frequency cutting and coagulation, intended to lower blood loss, quicken procedure times and provide cost savings for hospitals.
Subscribe to our email newsletter
Bovie intends to finalize the development and commercialization of the technology. As part of the agreement, Bovie granted a license to Boston Scientific until 2016 to uses outside of those fields listed above.
This agreement replaces a previously signed distribution and marketing agreement between the companies’ for the technology’s use in Boston Scientifics’s oncology business. The original development and manufacturing agreement signed in 2007 required Bovie to develop and manufacture certain products using Boston Scientifics’s intellectual property.
Andrew Makrides, president of Bovie Medical, said: “Adding strength to Bovie’s new product line, Mr Bob Rioux, who was at the forefront of the Boston Scientific tissue resection program, is joining Bovie as vice president of Advanced Resection Technologies. Mr Rioux’s combination of technical and marketing skills makes him ideally suited to commercialize these new products.”